MindMed is a company that specializes in developing innovative treatments for brain health disorders. It utilizes rigorous scientific methods to create a pipeline of product candidates, particularly focusing on the therapeutic potential of psychedelics and other novel compounds. These treatments aim to address unmet patient needs in areas such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Autism Spectrum Disorder (ASD). MindMed is committed to advancing the research and development of these therapies, although they are not yet approved by the FDA or other health authorities, meaning their safety and efficacy are still under evaluation.
51 - 200 employees
Founded 2019
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $30M Post-IPO Equity on 2022-09
22 hours ago
Seeking a Senior Director, Market Access at MindMed to shape market access strategies and engage stakeholders.
πΊπΈ United States β Remote
π΅ $200k - $273.6k / year
π° $30M Post-IPO Equity on 2022-09
β° Full Time
π Senior
π Director
22 hours ago
Drive evidence generation for MindMed's brain health products, overseeing HEOR research activities and strategic implementation.
πΊπΈ United States β Remote
π΅ $164.3k - $235k / year
π° $30M Post-IPO Equity on 2022-09
β° Full Time
π Senior
π Director
September 27
Oversee clinical studies for MindMed's brain health treatments.
πΊπΈ United States β Remote
π΅ $175k - $254.8k / year
π° $30M Post-IPO Equity on 2022-09
β° Full Time
π΄ Lead
π Director